This company is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
0P0 Overzicht aandelen
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 2/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
Aerie Pharmaceuticals, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$14.50 |
| 52 Week Hoogtepunt | US$15.70 |
| 52 Week Laag | US$4.58 |
| Bèta | -0.062 |
| 11 maand verandering | -5.23% |
| 3 maanden verandering | 33.03% |
| 1 Jaar Verandering | 63.84% |
| 33 jaar verandering | -14.71% |
| 5 jaar verandering | -71.88% |
| Verandering sinds IPO | 16.98% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| 0P0 | DE Pharmaceuticals | DE Markt | |
|---|---|---|---|
| 7D | 0% | -3.0% | -1.9% |
| 1Y | 63.8% | -13.2% | 12.3% |
Rendement versus industrie: 0P0 exceeded the German Pharmaceuticals industry which returned -10.8% over the past year.
Rendement versus markt: 0P0 exceeded the German Market which returned -21.6% over the past year.
Prijsvolatiliteit
| 0P0 volatility | |
|---|---|
| 0P0 Average Weekly Movement | 10.9% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stabiele aandelenkoers: 0P0's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: 0P0's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2005 | 376 | Raj Kannan | www.aeriepharma.com |
Aerie Pharmaceuticals, Inc. Samenvatting
| 0P0 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €735.53m |
| Inkomsten(TTM) | -€35.68m |
| Inkomsten(TTM) | €208.81m |
3.5x
P/S-verhouding-20.6x
Koers/WinstverhoudingIs 0P0 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 0P0 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$213.94m |
| Kosten van inkomsten | US$23.52m |
| Brutowinst | US$190.42m |
| Overige uitgaven | US$226.98m |
| Inkomsten | -US$36.55m |
Laatst gerapporteerde inkomsten
Sep 30, 2022
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.74 |
| Brutomarge | 89.01% |
| Nettowinstmarge | -17.09% |
| Schuld/Eigen Vermogen Verhouding | -190.6% |
Hoe presteerde 0P0 op de lange termijn?
Bekijk historische prestaties en vergelijking